N
RAPT

Nuveen’s RAPT Therapeutics RAPT Stock Holding History

Nuveen’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,616
Closed -$143K – 3384
2025
Q1 		$143K Hold
14,616
– – ﹤0.01% 3173
2024
Q4 		$185K Buy
14,616
+4,902
+50% +$62.3K ﹤0.01% 3219
2024
Q3 		$156K Hold
9,714
– – ﹤0.01% 3260
2024
Q2 		$237K Sell
9,714
-3,537
-27% -$163K ﹤0.01% 3188
2024
Q1 		$952K Buy
13,251
+308
+2% +$42.8K ﹤0.01% 2729
2023
Q4 		$2.57M Buy
12,943
+778
+6% +$96.3K ﹤0.01% 2293
2023
Q3 		$1.62M Buy
12,165
+1,478
+14% +$241K ﹤0.01% 2380
2023
Q2 		$1.6M Sell
10,687
-30,085
-74% -$4.69M ﹤0.01% 2458
2023
Q1 		$5.99M Sell
40,772
-569
-1% -$115K ﹤0.01% 1787
2022
Q4 		$6.55M Buy
41,341
+4,580
+12% +$733K ﹤0.01% 1761
2022
Q3 		$7.08M Buy
36,761
+23,089
+169% +$4.37M ﹤0.01% 1693
2022
Q2 		$2M Sell
13,672
-4,495
-25% -$599K ﹤0.01% 2437
2022
Q1 		$3.03M Hold
18,167
– – ﹤0.01% 2311
2021
Q4 		$2.7M Sell
18,167
-1,950
-10% -$521K ﹤0.01% 2418
2021
Q3 		$2.99M Buy
20,117
+13,372
+198% +$3.54M ﹤0.01% 2487
2021
Q2 		$1M Buy
6,745
+1,484
+28% +$277K ﹤0.01% 3004
2021
Q1 		$934K Sell
5,261
-224
-4% -$36.9K ﹤0.01% 2908
2020
Q4 		$867K Buy
5,485
+60
+1% +$13K ﹤0.01% 2856
2020
Q3 		$1.4M Sell
5,425
-575
-10% -$128K ﹤0.01% 2534
2020
Q2 		$1.39M Buy
+6,000
New +$928K ﹤0.01% 2481

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Nuveen's RAPT Position: Q2 2025 in Review

Nuveen sold out of RAPT Therapeutics (RAPT) in Q2 2025, closing a stake of 14,616 shares — an estimated $143K sold.

Nuveen first reported a position in RAPT in Q2 2020 and held it in 20 quarters. The position peaked at $7.08M in Q3 2022. 50 funds tracked by Wall St. Rank hold RAPT as of Q2 2025.

  • Nuveen reported no remaining RAPT Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 14,616 RAPT Therapeutics shares in Q2 2025, an estimated $143K.
  • Nuveen first reported a position in RAPT Therapeutics in Q2 2020 and held it in 20 quarters.
  • Nuveen's RAPT Therapeutics position peaked at $7.08M in Q3 2022.
  • 50 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.